Results 1 to 10 of about 45,683 (251)

Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review

Substance Abuse and Rehabilitation, 2017
Christa R Lewis,1,2 Hoa T Vo,1 Marc Fishman1,3 1Maryland Treatment Centers, Baltimore, MD, USA; 2Department of Psychology, Towson University, Towson, MD, USA; 3Department of Psychiatry, Johns Hopkins School of Medicine, Baltimore, MD, USA Abstract ...
Lewis CR, Vo HT, Fishman M
doaj   +1 more source

Reciprocal influences between overdose experiences and naloxone access among people who use drugs utilizing a syringe services program: a cross-lagged panel model

Harm Reduction Journal
Background The opioid epidemic continues to be one of the most pressing public health crises in the United States, with more than 80,000 overdose deaths in 2024.
Marina Plesons, Tyler Bartholomew, Hansel Tookes, Daniel Feaster   +3 more
doaj   +1 more source

The effects of heat and freeze-thaw cycling on naloxone stability

Harm Reduction Journal, 2019
Purpose The availability of take home naloxone (THN) was increased for Canadians in 2016, including access to kits via pharmacies. Unlike typical over-the-counter (OTC) and prescription drugs, THN kits may be stored in non-standard conditions, including ...
Dulcie Lai, Amy Trinh Pham, Praveen P. Nekkar Rao, Michael A. Beazely   +3 more
doaj   +1 more source

Bridging the Gap Between Knowledge and Practices Pertaining to Naloxone Use: A Single-Institution Experience in North Carolina

Journal of Patient-Centered Research and Reviews
Naloxone is a life-saving medication for opioid overdose, which claims many lives annually. This study investigated provider attitudes about, beliefs about, and barriers to naloxone use to inform an increase in provider prescription of naloxone.
Michael S. Argenyi, Gisele Bailey, Christopher J. McLouth, Erin Barnes, Candice J. McNeil   +4 more
doaj   +1 more source

Buprenorphine–naloxone [PDF]

Canadian Medical Association Journal, 2018
Tina, Hu, Larry, Nijmeh, Adam, Pyle
openaire   +2 more sources

The uptake of the pharmacy-dispensed naloxone kit program in Ontario: A population-based study.

PLoS ONE, 2019
BACKGROUND:Naloxone is a life-saving antidote for opioid overdoses. In June 2016, the Ontario government implemented the Ontario Naloxone Program for Pharmacies (ONPP) to enhance access to naloxone.
Beatrice Choremis, Tonya Campbell, Mina Tadrous, Diana Martins, Tony Antoniou, Tara Gomes   +5 more
doaj   +1 more source

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.

PLoS ONE, 2020
Rapid resuscitation of an opioid overdose with naloxone, an opioid antagonist, is critical. We developed an opioid receptor quantitative systems pharmacology (QSP) model for evaluation of naloxone dosing.
Ronald B Moss, Meghan McCabe Pryor, Rebecca Baillie, Katherine Kudrycki, Christina Friedrich, Mike Reed, Dennis J Carlo   +6 more
doaj   +1 more source

Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report

Harm Reduction Journal
Background Sublingual buprenorphine, approved for treatment of opioid use disorder since 2002, is most commonly available in co-formulation with naloxone.
Hannan M. Braun, Jessica L. Taylor, Sarah Axelrath   +2 more
doaj   +1 more source

Considering the Potential Benefits of Over-the-Counter Naloxone

Integrated Pharmacy Research and Practice, 2021
Kirk E Evoy,1 Lucas G Hill,2 Corey S Davis3 1University Health, Department of Pharmacy, The University of Texas at Austin College of Pharmacy, San Antonio, TX, USA; 2Pharmacy Practice, The University of Texas at Austin College of Pharmacy, Austin, TX ...
Evoy KE, Hill LG, Davis CS
doaj  

Naloxone prescription fills and use by patients treated for opioid use disorder by telehealth

Drug and Alcohol Dependence Reports
Background: It is unknown how many people in treatment for opioid use disorder (OUD) have naloxone, use naloxone, and what their perceptions and barriers to obtaining it are.
Scott G. Weiner, Emily N. Miller, Barbara Burke, Brian Clear   +3 more
doaj   +1 more source